J&J's Ethicon gains reprocessing tech with SterilMed takeover
This article was originally published in Clinica
Ethicon Endo-Surgery, a unit of Johnson & Johnson, has agreed to acquire privately-held SterilMed, a specialist in the reprocessing and remanufacturing of medical devices. Financial details of the agreement were not disclosed. The deal will broaden Ethicon's portfolio and allow it to expand in this rapidly-growing segment, while SterilMed will benefit from Ethicon's added scale, scope and experience. Maple Grove, Minnesota-based SterilMed will be managed as part of the Ethicon Endo-Surgery franchise, but will keep its name and continue to operate as a stand-alone company. SterilMed offers products and services including reprocessing, equipment repair, and pre-owned equipment sales with the promise of helping healthcare providers lower costs and reduce waste.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.